LBPH - Longboard Pharmaceuticals EPS beats by $0.29 May, 10 2021 04:56 PM Longboard Pharmaceuticals Inc. Longboard Pharmaceuticals (LBPH): Q1 GAAP EPS of -$0.84 beats by $0.29.Cash and cash equivalents balance of $120.9M.Press Release For further details see: Longboard Pharmaceuticals EPS beats by $0.29